These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 38683460)
1. In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials. Soliman PS; Curley DE; Capone C; Eaton E; Haass-Koffler CL Psychopharmacology (Berl); 2024 Jun; 241(6):1101-1110. PubMed ID: 38683460 [TBL] [Abstract][Full Text] [Related]
4. Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review. Hovmand OR; Poulsen ED; Arnfred S; Storebø OJ J Psychopharmacol; 2023 Jul; 37(7):649-659. PubMed ID: 37403379 [TBL] [Abstract][Full Text] [Related]
5. Psychedelic renaissance: Revitalized potential therapies for psychiatric disorders. Rhee TG; Davoudian PA; Sanacora G; Wilkinson ST Drug Discov Today; 2023 Dec; 28(12):103818. PubMed ID: 37925136 [TBL] [Abstract][Full Text] [Related]
6. [Efficacy of psychedelics in psychiatry, a systematic review of the literature]. Berkovitch L; Roméo B; Karila L; Gaillard R; Benyamina A Encephale; 2021 Aug; 47(4):376-387. PubMed ID: 33888297 [TBL] [Abstract][Full Text] [Related]
7. United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020. Barnett BS; Parker SE; Weleff J Int J Drug Policy; 2022 Jan; 99():103473. PubMed ID: 34624734 [TBL] [Abstract][Full Text] [Related]
8. Psychedelics for treatment resistant depression: are they game changers? Kalfas M; Taylor RH; Tsapekos D; Young AH Expert Opin Pharmacother; 2023; 24(18):2117-2132. PubMed ID: 37947195 [TBL] [Abstract][Full Text] [Related]
9. Expectancy in placebo-controlled trials of psychedelics: if so, so what? Butler M; Jelen L; Rucker J Psychopharmacology (Berl); 2022 Oct; 239(10):3047-3055. PubMed ID: 36063208 [TBL] [Abstract][Full Text] [Related]
10. Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders. Lowe H; Toyang N; Steele B; Grant J; Ali A; Gordon L; Ngwa W Molecules; 2022 Apr; 27(8):. PubMed ID: 35458717 [TBL] [Abstract][Full Text] [Related]
11. Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review. Breeksema JJ; Kuin BW; Kamphuis J; van den Brink W; Vermetten E; Schoevers RA J Psychopharmacol; 2022 Oct; 36(10):1100-1117. PubMed ID: 36017784 [TBL] [Abstract][Full Text] [Related]
12. Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis. Goldberg SB; Shechet B; Nicholas CR; Ng CW; Deole G; Chen Z; Raison CL Psychol Med; 2020 Dec; 50(16):2655-2666. PubMed ID: 33143790 [TBL] [Abstract][Full Text] [Related]
13. A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy. Luoma JB; Chwyl C; Bathje GJ; Davis AK; Lancelotta R J Psychoactive Drugs; 2020; 52(4):289-299. PubMed ID: 32529966 [TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
15. Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine. De Gregorio D; Aguilar-Valles A; Preller KH; Heifets BD; Hibicke M; Mitchell J; Gobbi G J Neurosci; 2021 Feb; 41(5):891-900. PubMed ID: 33257322 [TBL] [Abstract][Full Text] [Related]